Upfront surgery versus preoperative chemoradiotherapy: a comparative survival analysis for stage II/III resectable rectal cancer

Upfront TME may represent a viable treatment option for selected patients with LARC, particularly those without MRF involvement, providing comparable oncologic outcomes to the standard nCRT approach.

Authors

Institutions

Publication Details

Journal
Annals of Coloproctology
Published
2026-02-26
DOI
https://doi.org/10.3393/ac.2025.00724.0103
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upfront surgery versus preoperative chemoradiotherapy: a comparative survival analysis for stage II/III resectable rectal cancer

Thitithep Limvorapitak, Nattapanee Sukphol
Annals of Coloproctology
Colorectal Cancer Surgical Treatments
article

Upfront surgery versus preoperative chemoradiotherapy: a comparative survival analysis for stage II/III resectable rectal cancer

Thitithep Limvorapitak, Nattapanee Sukphol
article en

Abstract

Upfront TME may represent a viable treatment option for selected patients with LARC, particularly those without MRF involvement, providing comparable oncologic outcomes to the standard nCRT approach.

Annals of ColoproctologyVol. 42(1)
Chulalongkorn University (TH), Chulabhorn Hospital (TH)
Openalex Percentile: Top 42%
Colorectal Cancer Surgical Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Upfront surgery versus preoperative chemoradiotherapy: a comparative survival analysis for stage II/III resectable rectal cancer — Thitithep Limvorapitak, Nattapanee Sukphol · Annals of Coloproctology (2026) | TGRS Research Map | TGRS